Protein analysis Protoarray
Tuesday, 16 September, 2008
Invitrogen Corporation has launched the ProtoArray Human Protein Microarray v4.1 which enables customers to screen biological samples or labeled probe of interest against approximately 8,200 unique human proteins in as little as one day. This technology has a broad range of applications - identification of novel protein biomarkers specific for infectious diseases, cancers, and autoimmune diseases; mapping protein-protein interactions important to biochemical pathways; identification of kinase/ ubiquitin ligase substrates for target discovery and validation; antibody specificity profiling for research and therapeutic antibody development; and small molecule-protein radioligand profiling for drug candidate selection and development Invitrogen Tel: 1800 331 627 www.invitrogen.com/protoarray.
mRNA therapy found to prevent recurrence of melanoma
Merck and Moderna have announced positive topline results from their Phase 3 trial of a...
A high-performance method for CRISPR off-target nomination
A new study provides evidence that can help gene editing developers prioritise biologically...
High doses of fertility drug linked to pregnancy risks
High doses of clomiphene citrate, accumulated over multiple fertility treatment cycles, could...
